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Abstract: COPD is recognized as having a series of comorbidities potentially related to 
common inflammatory processes. Periodontitis is one of the most common human inflammatory 
diseases and has previously been associated with COPD in numerous observational studies. As 
periodontitis and COPD are both chronic, progressive conditions characterized by neutrophilic 
inflammation with subsequent proteolytic destruction of connective tissue, it has been proposed 
that they share common pathophysiological processes. The mechanisms proposed to link COPD 
and periodontitis include mechanical aspiration of oral contents into the respiratory tree, over-
spill of locally produced inflammatory mediators into the systemic circulation or oral or lung-
derived bacteremia activating an acute-phase response and also reactive oxygen species (ROS) 
and cytokine release by systemic neutrophils at distant sites. Studies of systemic neutrophils 
in COPD and chronic periodontitis describe altered cellular functions that would predispose 
to inflammation and tissue destruction both in the lung and in the mouth, again potentially 
connecting these conditions. However, COPD and periodontitis also share risk factors such as 
age, chronic tobacco smoke exposure, and social deprivation that are not always considered in 
observational and interventional studies. Furthermore, studies reporting associations have often 
utilized differing definitions of both COPD and periodontitis. This article reviews the current 
available evidence supporting the hypothesis that COPD and inflammatory periodontal disease 
(periodontitis) could be pathologically associated, including a review of shared inflammatory 
mechanisms. It highlights the potential limitations of previous studies, in particular, the lack 
of uniformly applied case definitions for both COPD and periodontitis and poor recognition 
of shared risk factors. Understanding associations between these conditions may inform why 
patients with COPD suffer such a burden of comorbid illness and new therapeutic strategies for 
both the diseases. However, further research is needed to clarify factors that may be directly 
causal as opposed to confounding relationships.
Keywords: inflammation, emphysema, dental health, smoking, neutrophil
Introduction
COPD is defined as a chronic, progressive disease characterized by airflow obstruction 
due to an enhanced chronic inflammatory response within the airways.1,2 COPD is an 
important cause of morbidity and mortality and is now recognized as having a series 
of comorbidities hypothesized to be related to a common systemic or organ-specific 
inflammatory process. This concept is reflected in the updated Global initiative for 
chronic Obstructive Lung Disease (GOLD) classification systems for COPD. GOLD 
now recognizes the significance of extra-pulmonary effects of COPD and that comor-
bidities contribute to the overall severity of disease and as such should be actively 
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sought and treated.3 An observational study found that .97% 
of a COPD cohort had at least one other comorbidity, 
with .50% having at least 4.4 This impacts the health care 
costs of COPD patients with multiple comorbidities that are 
4.7 times higher than those with no comorbidity.5
Respiratory comorbidities associated with COPD include 
bronchiectasis,6 asthma, pulmonary fibrosis,7 and lung 
cancer,7 but extra thoracic chronic inflammatory disease also 
co-occurs.8 Cardiovascular diseases are the most common,9 
including hypertension,7 venous thromboembolism, ischemic 
heart disease, arrhythmias,7,10 and heart failure.7,11 This high 
prevalence may, in part, reflect the presence of common 
risk factors including age, smoking, and sedentary lifestyle, 
but even when such factors are accounted for, there remains 
increased risk, supporting linked pathogenic drivers of dis-
ease. Cerebrovascular disease,9,10,12 cognitive impairment,13 
diabetes,9,14 skeletal muscle dysfunction,15 low bone mineral 
density and osteoporosis11,16 also frequently accompany 
COPD and support the hypothesis that the pathophysiology 
underlying these conditions relates to systemic inflamma-
tion and hypoxia.11,13 Recently, there has been increasing 
interest in the association between several chronic diseases 
including COPD and the chronic inflammatory oral disease, 
periodontitis, although the underlying nature of the associa-
tion is unclear.
Periodontitis
Teeth are attached to the surrounding and supporting alveolar 
bone by periodontal ligament fibers that run from the bone 
into the cementum on the entire root surface of teeth. 
Periodontitis is a chronic, bacteria-initiated inflammatory 
disease, affecting ~50% of adults, with 11.2% suffering from 
severe periodontitis.17 Sites with periodontitis exhibit clinical 
signs of gingival inflammation and loss of connective tissue 
attachment. Plaque biofilm accumulation above and below the 
gingival margin leads to a dysbiosis (a microbial imbalance 
or maladapted inflammatory response to bacteria), which in 
turn drives a dysfunctional host-immune-inflammatory 
response, connective tissue destruction, and the formation 
of periodontal pockets.18 The active periodontal lesion is 
neutrophil and B-cell dominant and associated with systemic 
inflammation, probably arising due to repeated bacteremias 
of periodontal origin activating an acute-phase response.19 
This subsequently triggers priming and activation of periph-
eral blood neutrophils with an exaggerated release of reactive 
oxygen species (ROS) and pro-inflammatory cytokines.20 
Finally, the local destructive inflammatory processes lead to 
loss of alveolar bone and subsequent tooth loss.18
Generally, a diagnosis of periodontitis is based on the 
combination of periodontal and gingival inflammation, 
determined as the presence of sub-gingival bleeding on 
probing (BOP), the number and depth of periodontal pockets, 
the amount of clinical attachment loss (CAL), and presence 
of radiologically evaluated alveolar bone loss.21–23 Probing 
pocket depth (PPD) and CAL are measured by using manual 
or controlled force periodontal probes. The PPD is the dis-
tance from the gingival margin to the base of the gingival 
sulcus (or periodontal pocket). CAL is the distance from the 
cemento–enamel junction to the base of the sulcus or peri-
odontal pocket.21 Figure 1 summarizes these parameters.
Periodontitis has also been linked to a number of other 
chronic systemic diseases as well as to COPD. These include 
diabetes mellitus,24,25 rheumatoid arthritis,25,26 and cardio-
vascular diseases. The increased prevalence of cardiovas-
cular disease,27,28 hypertension,25 and stroke in periodontal 
disease25,29 has been attributed to a common susceptibility 
hypothesis, that of direct bacterial invasion of blood vessels, 
and/or a systemic inflammatory response leading to increased 
circulating cytokines that damage vascular endothelium.30 
Importantly, treating periodontitis in patients with common 
comorbidities has shown to be an effective way of reducing 
both financial costs and admissions for cardiovascular 
disease and diabetes mellitus,31 lending credence to this 
hypothesis. Thus, both periodontitis and COPD occur with a 
similar spectrum of comorbid disease. This needs recognition 
?????????
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??????????????????
??????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????
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Figure 1 Probing pocket depth (PPD – distance in millimeter from gingival margin 
to base of pocket) and clinical attachment loss (CAL – distance in millimeter from 
cement–enamel junction to base of pocket).
Note: Copyright © 2002. Adapted with permission from Quintessence Publishing Co 
Ltd. Chapple ILC, Gilbert AD, wilson NHF. Understanding Periodontal Diseases: Assessment 
and Diagnostic Procedures in Practice: 1 (Quintessentials: Endontics). Quintessence Publishing 
Co Ltd.114
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and documentation when reporting associations between 
periodontitis and COPD as it likely reflects a subgroup of 
patients with a predisposition or the presence of common 
etiological factors for this spectrum of diseases.
In keeping with this, there are important similarities in 
both the mechanisms underpinning periodontitis and COPD 
and the risk factors for developing these conditions that are 
worthy of exploration. Both periodontitis and COPD are 
chronic and progressive conditions characterized by neutro-
philic inflammation with subsequent proteolytic destruction 
of connective tissues.32–34 Of note, not all patients with com-
mon risk factors (chronic cigarette smoke inhalation for both 
condition and poor dental hygiene for periodontitis) develop 
disease, for example, only 20% of smokers go on to develop 
significant COPD,35 supporting the concept of susceptibility. 
They also share several other common risk factors including 
age and poor socioeconomic status.33,36
As both the conditions result in tissue destruction by neu-
trophilic inflammation, it has been suggested that they share 
common pathophysiological processes. If true, this would 
have important implications for the diagnosis and potentially 
even the treatment of these conditions, as diagnosing and 
controlling one with an appropriate intervention may reduce 
severity and/or progression in the other.
Mechanisms
There are several mechanisms that may potentially link 
respiratory disease with periodontitis.
Aspiration of potentially pathogenic 
bacteria
The first is mechanical; the aspiration of oral contents includ-
ing microbial pathogens into the respiratory tract with airway 
inflammation and remodeling (caused by COPD) supporting 
adherence, immune evasion, colonization, and subsequent 
pulmonary infections. Micro-aspiration is common even 
in healthy patients and frequently occurs during sleep. 
Studies have shown that typical volumes aspirated are of a 
magnitude likely to contain bacterial pathogens.37 In healthy 
patients, there are defense mechanisms to ensure that, despite 
aspiration, the distal airway and lung parenchyma remain 
protected.38 This clearance is mediated by both mechanical 
and immunological mechanisms and includes cough and 
mucociliary clearance of pathogens and phagocytosis of 
microorganisms by local immune cells.37 However, in 
patients with underlying chronic health problems, aspiration 
of oral secretions containing bacterial pathogens may not 
always be cleared.39,40 In these cases, the periodontium could 
act as a repository of bacteria, enhancing respiratory tract 
colonization and inflammation. For COPD patients, this is 
important as recurrent infections causing exacerbations are 
known to amplify the decline in lung function41 but current 
evidence to support the link between COPD and periodontitis 
remains, at best, indirect.
Oral colonization by respiratory pathogens, fostered by 
poor oral hygiene and periodontal diseases, seems to be 
associated with nosocomial pneumonia in some studies. 
A recent meta-analysis identified 11 observational studies 
of intubated patients where periodontal disease was assessed 
with respiratory infections as an outcome.42 Approximately 
half of these studies reported an association between dental 
status and ventilator-associated pneumonia, with one study43 
reporting that the pathogen thought to cause pneumonia had 
first colonized the dental plaque biofilm. However, these 
studies were conducted in extremely unwell patients who 
were at significant risk of pneumonia and some did not 
include a control population. Studies have associated pneu-
monia with poor dental hygiene and periodontitis in both 
the community and the outpatient setting but most do not 
provide information about potentially confounding factors 
(comorbidities, smoking status, etc) or information about 
microbial pathogens. There are five intervention trials44–48 
where a mixed population of patients received treatments 
to lower oropharyngeal bacterial load, and a meta-analysis 
suggested that oral hygiene and antibiotic intervention 
significantly reduced the risk of developing pneumonia in 
these populations, supporting a causal link between oral 
pathogens and lower respiratory tract infections.42 However, 
once again, the majority of studies were conducted in an 
intensive care setting, and it is unclear whether the findings 
are generalizable.
Approximately 10 bacterial species have been identi-
fied as putative pathogens in inflammatory periodontal 
diseases. These are mainly gram-negative rods and include 
Aggregatibacter actinomycetemcomitans in aggressive 
periodontitis and Porphyromonas gingivalis, Treponema 
denticola, and Tanerella forsythia in chronic periodontitis.49 
However, these are not commonly associated with lower 
respiratory infections in the general population or in COPD, 
and there are no studies in COPD patients that have directly 
associated oral pathogens with COPD exacerbations.
Periodontitis as an inflammatory 
reservoir
Alternative hypotheses linking the two conditions suggest 
bacterial aspiration is not required to initiate shared pathology. 
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The entry of periodontal bacteria into the vasculature during 
eating and tooth brushing can trigger an acute-phase response 
in the systemic circulation as evidenced by elevated serum 
levels of inflammatory mediators.21 In keeping with this 
hypothesis, periodontitis is now recognized as a significant 
and independent risk factor for atherogenic cardiovascular 
disease, and the mechanisms seem to involve periodontal 
pathogens disseminating throughout the vasculature.27 
Moreover, peripheral blood neutrophils from periodontitis 
patients exhibit hyper-reactivity to bacterial stimuli and 
hyperactivity (in absence of a stimulus) with respect to ROS 
and pro-inflammatory cytokine release.50–54 Alternatively, 
the local inflammatory response to periodontitis could lead 
to an “overspill” of periodontal cytokines into the systemic 
circulation, with subsequent distant inflammatory sequelae. 
Evidence to support this is weak55 although this may just 
reflect the rapid distribution and binding of pro-inflammatory 
cytokines to receptors as argued for COPD.56 Nevertheless 
pro-inflammatory cytokine networks have been found to be 
activated in periodontitis tissues57 and many of the same 
cytokines have been found to be raised in blood58–60 and lung 
secretions from patients with COPD61–65 at least supporting 
a common inflammatory process.
If present, any shared mechanisms are likely to impact 
on both the diseases, with periodontal inflammation and 
infection impacting on lung pathology and inflammatory 
lung disease amplifying periodontal disease risk. These 
mechanisms are summarized in Figure 2.
The most compelling evidence for a common mecha-
nism causing both periodontitis and COPD is that of the 
neutrophilic inflammation and neutrophil-mediated tissue 
damage that characterizes both the diseases.
Neutrophilic inflammation in COPD
Neutrophils have a key role in inflammatory processes, and 
there is compelling evidence to support their role in the 
pathogenesis of COPD. Neutrophils have been implicated 
in the development and progression of all of the pulmonary 
features of COPD in animal and cell studies, including 
emphysema through the release of destructive mediators 
such as neutrophil elastase and matrix metalloproteinases 
(MMPs)66 and chronic bronchitis through mucous gland 
hyperplasia.68 Pulmonary neutrophilic inflammation is a 
feature of cigarette smoking, but importantly, in patients with 
COPD it is sustained even following smoking cessation,68,69 
though not in smokers without airflow obstruction.
As well as being increased in number in bronchial 
tissue and airway secretions, there is evidence to suggest 
that neutrophils in COPD patients are also dysfunctional. 
Circulating neutrophils produce more ROS than those from 
healthy nonsmokers or smokers with normal lung function.70 
The cells also have enhanced, rapid, and tortuous chemot-
actic responses to inflammation and evidence of increased 
degranulation and tissue destruction both in vitro and 
systemically.71,72
The level of neutrophilic inflammation in airways cor-
relates with disease severity and progression in COPD 
whether measured by lung physiology, radiologically, or 
health status.63,73–76 These data support the concept that 
activated neutrophils play an important role in lung injury 
and emphysema through neutrophilic release of inflam-
matory cytokines, destructive proteases such as neutrophil 
elastase, proteinase 3, MMP-8, and MMP-977–79 all of which 
are capable of degrading components of the extracellular 
matrix, promoting inflammatory responses in the surround-
ing tissue80 and increasing the generation of ROS.70 Cigarette 
smoking further enhances recruitment of these activated 
neutrophils with more subsequent release of tissue destruc-
tive proteinases,81 supporting the faster physiological decline 
seen in COPD patients who continue to smoke.
Neutrophils in periodontitis
Periodontitis is also characterized by a neutrophilic infiltrate.82 
A review by Hajishengallis83 highlighted the increased 
prevalence of periodontitis in conditions characterized 
by abnormal neutrophil function. These include defective 
neutrophil production as seen in autoimmune neutropenia 
or chemotherapy-induced neutropenia, defective neutrophil 
release from the bone marrow as seen in WHIM (warts, 
hypogammaglobulinemia, infections, and myelokathexis), 
inherited leukocyte adhesion deficiency, excessive neutrophil 
activation, deficient clearance of neutrophils as in autoim-
mune inflammatory diseases including systemic lupus 
erythematosus and the Papillon–Lefevre syndrome (neutro-
phil cathepsin C deficiency).
There is evidence of both hyper-reactive and hyperactive 
neutrophil functions in periodontitis. Systemic neutrophil 
chemotaxis studies in patients with chronic periodontitis 
showed reduced speed (movement in any direction), velocity 
(speed of movement toward the chemoattractant), and accu-
racy (accuracy of movement toward the chemoattractant).84 
This behavior improved after treatment of periodontitis,85 
suggesting a causal link between periodontitis and the 
systemic cell function. A similar pattern of neutrophil migra-
tion has been described in COPD where cells displayed 
poor migratory accuracy but with random movement in all 
directions at increased speed.72 Recent publications have also 
described compromised neutrophil bacterial phagocytosis in 
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periodontitis86 (studies in COPD are less clear); enhanced 
neutrophil-derived ROS87,88 and increased NET formation in 
both COPD and periodontitis,89,90 all of which could contrib-
ute to the sustained inflammation that characterizes both the 
conditions.34,53 The cause for such injurious cell behavior is 
unclear, and it is unknown whether neutrophil dysfunction 
precedes or is a consequence of disease. However, these 
impaired neutrophil functions may mean that the host is less 
able to deal efficiently with bacteria either in the periodon-
tium or in the lung. Furthermore, as neutrophils release both 
proteinases91,92 and ROS while migrating through complex 
tissues,93 it is possible that the tortuous abnormal migratory 
pathways lead to increased by-stander tissue damage, thereby 
perpetuating the inflammatory response leading to excess 
tissue damage seen as alveolar bone loss in the mouth and 
emphysema and COPD in the lung. This concept has been 
supported in COPD where there is systemic evidence of 
increased proteinase activity,94 but remains unconfirmed in 
periodontitis.
COPD and periodontitis
There is evidence of a clinical association between periodon-
titis and COPD including a meta-analysis of 14 observational 
studies.36 The overall sample size represented 3,988 COPD 
?????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????? ????
??????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????
????????????????????????????????????? ????????????????????????????????????????????
??????????????????????????????????????????????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????
???????? ???????? ????????????????????? ????????????????
????????????????? ???????????? ??????????
Figure 2 Shared inflammatory mechanisms that might facilitate disease progression in both COPD and periodontitis.
Notes: (1) Periodontal bacteria are found in oral secretions and could result in systemic inflammation by two mechanisms. (2a) Inflammation of the periodontium 
causes production of local cytokines and other biologically active molecules that enter the systemic circulation by diffusion. These activate both the endothelium and 
circulating immune cells, which contribute to the inflammatory burden by the release of activating and destructive mediators. This process also occurs in the lungs, causing 
pulmonary inflammation. (3) Protective secretions and mucins are destroyed by neutrophils and hydrolytic salivary enzymes produced by bacteria. (4) Unresolved periodontal 
inflammation results in damage to periodontal tissue and alveolar bone. (5) Cytokines, bacteria, neutrophils, and other biologically activated mediators are aspirated into 
the respiratory tree and initiate bronchial inflammation perpetuated by upregulation of the expression of adhesion receptors on mucosal surfaces. (6) Pro-inflammatory 
mediators serve as an additional inflammatory stimulus and induce a more active response in the lungs.99 (7) Bronchial inflammation facilitates microbial colonization by 
oropharyngeal bacteria39,98,107,112,113 and local tissue destruction.67 (8) Infected and inflamed bronchial secretions increase the inflammatory load in the periodontium following 
expectoration. An alternative mechanism is represented in (2b). Periodontal pathogens enter gingival vasculature through micro-ulcerations in the epithelium allowing 
hematogenous dissemination of inflammatory mediators and bacteria.40 This bypasses stages 3–6 and has a resultant influence at stage 7.
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patients and 22,871 controls. The authors reported a pooled 
odds ratio (OR) for having COPD in populations with perio-
dontitis as 2.08 (95% confidence interval [CI] 1.48–2.91; 
P,0.001).
Alternatively, data from a large longitudinal COPD 
cohort study found that patients had a significantly increased 
cumulative incidence of periodontitis with adjusted hazard 
ratio (HR) of 1.20 (95% CI 1.15–1.25) rising to 3.17 (95% CI 
2.81–3.57) in the subgroup that had required hospitalization 
for COPD.33 The risk of developing periodontitis increased 
proportionately with the annual number of emergency room 
visits and admissions for COPD.33 A further in-patient study 
supported these findings, noting significantly increased 
markers of periodontitis in a hospitalized COPD group com-
pared with an in-patient control group (probing depth [PD] 
2.57±0.85 vs 1.76±0.7, P,0.0001; and clinical attachment 
level [CAL] 3.16±0.53 vs 2.12±0.92, P,0.0001).95
A recent, large cross-sectional study found that after 
adjustment for the confounders of age, smoking, socio-
economic status, and dental habits, moderate periodontitis 
was still associated with COPD in male patients (relative 
risk =1.38, 95% CI 1.12–2.05), but not female patients, and 
the relative risk of severe periodontitis in the male group was 
1.23 (95% CI 1.06–1.56).96 Prasanna also found significantly 
higher periodontal indices in COPD patients in comparison 
with non-COPD controls that persisted after correction for 
age.40 A Chinese case–control study of 306 dentate COPD 
patients and 328 dentate healthy controls found the COPD 
cohort had fewer remaining teeth and a greater percentage 
of the remaining teeth had CAL $4 mm.97 In addition, an 
Indian observational study of 150 dentate patients also found 
patients with COPD had significantly higher mean CAL 
measurements.98
Using a different measure of periodontitis, Leuckfeld 
et al assessed orthopantomograms in a retrospective 
cross-sectional study of patients evaluated for lung transplant. 
They found a significant difference in radiographically deter-
mined periodontitis, with 44% of COPD patients affected 
compared with 7% of non-COPD patients. The results also 
remained significantly different after adjustment for age, 
gender, and smoking.99
Several studies have also found associations between 
indices of periodontitis and lung function measurements. 
An observational study of 102 dentate COPD patients found 
significantly worse indices of periodontitis after adjusting for 
age and smoking.100 The same study confirmed a significant 
correlation between several adverse periodontal outcomes; 
CAL, PD, and gingival index (GI) and forced expiratory 
volume in 1 s (FEV
1
) (r=-0.63, -0.60, and -0.44, respec-
tively; P,0.0001). A large German prospective cohort study 
of 1,268 people found that pulmonary function parameters 
were significantly associated with CAL measurements after 
adjustment for confounding factors.101
However, other studies have failed to find such asso-
ciations. Bergstrom et al102 found that smoking rather than 
COPD was the major risk factor for periodontal pocket depth 
(OR 24.2; 95% CI 2.0–286.8). One analysis of the NHANES 
III survey found no relationship between the two diseases, 
although subgroup analysis found an association in current 
smokers aged $30 years with CAL $4 mm.103 Finally, a 
cross-sectional study of 392 dentate patients with COPD 
was also unable to find significant differences between peri-
odontal measurements and exacerbation rates.104 However, 
the lack of consistency in findings also reflects the lack of 
consistency in case definitions, data collection, and analysis 
(eg, case definitions vs continuous outcome variables such 
as PPD, CAL, etc).
Potential limitations of these 
studies
The data summarized above remains controversial as there 
are several potential limitations in the studies that have 
assessed associations between COPD and periodontitis.
First, many studies have not accounted for common 
risk factors that might contribute to the presence of both 
periodontitis and COPD. For example, the longitudinal 
study by Shen et al failed to correct for smoking status, 
dental habits, or socioeconomic status,33 and no adjustment 
was made for socioeconomic factors in the radiographic 
study by Leuckfeld et al.99 Where appropriate allowance had 
occurred, the OR for having COPD in the populations with 
periodontitis (OR 1.78; 95% CI 1.23–2.58) was lower than 
initially reported.36
Second, the manner in which the diseases are diagnosed 
in the epidemiological studies has a significant impact on the 
results of prevalence and associations. For epidemiological 
studies, a case definition needs to be easily and accurately 
measurable21 and a uniform definition is essential to allow 
calculations and comparisons of relative risks to be made 
across studies.105
Most studies investigating associations between COPD 
and periodontitis base the diagnosis of COPD on post- 
bronchodilator spirometry and GOLD staging.95,96,100,102,103,106 
However, some authors used pre-bronchodilator spirometry,107 
which could lead to an overestimation of the prevalence of 
COPD, others report lung function measurements but not 
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whether pre- or post-bronchodilation,40,98 and one study 
failed to mention how COPD was confirmed.99 A German 
prospective study used body plethysmography to determine 
lung function,101 whereas Shen et al used International Clas-
sification of Diseases, Ninth Revision, Clinical Modification 
(ICD-9-CM) codes that do not provide details of how the 
diagnosis was established.33
Third, there is also great variation in how authors define 
periodontitis. Savage et al conducted a systematic review of 
3,472 papers analyzing 104 of these in detail and found that only 
15 studies gave a definition of periodontitis.23 This is a continu-
ing problem in the literature studying COPD and periodontitis. 
Published studies have used various periodontal measurement 
parameters for analysis but do not always give a specific 
definition for the disease,40,95,100,104,107 which likely reflects the 
lack of a uniformly accepted definition of periodontitis. When 
defined, measurements to determine the presence or severity 
of periodontitis vary and include one or a combination of the 
PPD, CAL, bleeding index (BI), gingival index (GI), plaque 
index (PI), or oral hygiene index (OHI), reflecting the lack of 
an agreed GOLD standard. Wang et al measured PPD, CAL, 
and BI, but in their statistical analysis report, the percentage of 
sites with PD of $4 and 5 mm and CAL $3 and 4 mm,97 since 
these values are regarded as representing active periodontitis 
(PPD .4 mm). Deo et al measured PPD, CAL, and OHI but 
reported only on CAL and OHI.98 Other studies have favored 
the use of PD and CAL in combination.103,106 However, Hyman 
et al only found significant associations with CAL alone.103 
This may reflect the fact that PPD used in isolation accounts 
only for current disease status, whereas CAL represents the 
cumulative periodontal tissue damage with age.102
The studies by Chung et al and Kim et al used the crude 
screening index called the World Health Organization com-
munity periodontal index to screen for periodontitis in large 
populations, defining the disease as present with a score of 3 
(.3.5 mm pocket) or 4 (.5.5 mm pocket).96,108 Mean pocket 
depth of $4 mm was arbitrarily chosen as a cut-off point to 
define periodontitis in the Bergstrom et al’s study,102 since 
this value represents clinical pathology, and pocket depths 
of missing teeth were set as the values of neighboring tooth 
sites. Interestingly, when analyzed separately, recession 
was more prevalent in smokers, suggesting measurement of 
pocket depth alone may underestimate disease severity in 
smoking groups.102
Two further studies employed very different methods to 
define periodontitis. Leuckfeld et al used mean marginal bone 
level $4 mm on orthopantomograms,99 and Shen et al used 
ICD-9-CM codes.33 Although radiographs allow assessment 
of cumulative effects on alveolar bone loss, they do not allow 
assessment of current disease activity, they are not always 
available, and radiation exposure for epidemiological pur-
poses is unlikely to be acceptable.22
In younger populations, PPD and CAL correlate well, but 
as people age, gingival recession and therefore measures of 
attachment loss become a normal part of the ageing process. 
In addition, increased PPD may arise as a false-positive 
clinical finding. This can occur when gingival tissues become 
swollen due to inflammation (in the absence of periodontitis), 
thus moving the gingival margin upwards (false pocket-
ing). Periodontitis can progress without significant pockets 
if gingival recession is also present, as frequently found in 
smokers.23 The use of CAL alone may also overestimate 
periodontitis because attachment loss can occur with non-
inflammatory gingival recession, such as that induced by 
trauma from over tooth brushing.21
During the 5th European Workshop in Periodontology, 
a two threshold level criterion was proposed to diagnose 
periodontitis. This was the presence of proximal attachment 
loss of $3 mm in $2% of nonadjacent teeth to diagnose 
incipient cases and the presence of proximal attachment loss 
of $5 mm in $30% of teeth to determine severe disease. 
However, the authors of this proposal also stated that a single-
index measurement of periodontitis does not uniformly reflect 
the disease and that these criteria are designed for use in 
studies determining risk factors for periodontitis and not the 
prevalence of periodontitis.105
In an attempt to produce a standard case definition for 
periodontitis, the Division of Oral Health at the Centers 
for Disease Control and Prevention (CDC) alongside the 
American Academy of Periodontology appointed a working 
group in 200321 to define severe and moderate periodontitis. 
Severe periodontitis required involvement of two or more 
interproximal sites with CAL $6 mm and one or more 
interproximal sites with PD $5 mm. Moderate periodontitis 
required involvement of two or more interproximal sites with 
CAL $4 mm or $2 interproximal sites with PD $5 mm.21 
Since the development of these definitions, Eke et al as part 
of the group at the CDC have added a further definition 
classifying mild periodontitis as $2 interproximal sites with 
attachment loss $3 mm and $2 interproximal sites with 
PD $4 mm, or one with PD $5 mm.109 These authors applied 
their criteria to a group of 456 dentate individuals and found 
that the addition of mild cases increased the total prevalence 
of periodontitis from 22.3% to 29.4%. They also applied 
the criteria established by the 5th European Workshop and 
found the European criteria gave a greater prevalence of 
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42% for incipient cases, compared with 24.6% for the CDC 
criteria, although the prevalence was the same for severe 
periodontitis (4.8%).109
The current American classification system was devel-
oped in 1999 at the International Workshop for a Classifica-
tion of Periodontal Diseases and Conditions. This led to the 
addition of a subcategory for gingival conditions, recognition 
of subtypes of periodontitis, and importantly the clarification 
of periodontitis as the manifestation of systemic disease.110 
In 2014, a task force developed a clinical interpretation of 
this classification, addressing the concept of attachment 
levels in the diagnosis of periodontitis. This recognized 
the importance of attachment levels but also difficulties in 
accurate measurement and interpretation especially in those 
with non-inflammatory gum recession. Clarification was also 
made regarding localized versus generalized periodontitis, 
and these criteria are now widely adopted in the USA.111
Importantly, these variations in definition of periodontal 
disease will influence prevalence rates and hence ORs of both 
COPD in periodontitis and vice versa.
Socioeconomic status
Both COPD and periodontitis share the common risk factors 
of poor socioeconomic status and smoking,33,36 and it is 
possible that the link seen between the two conditions also 
reflects poor oral health in combination with other factors 
such as smoking, poor nutrition, poor self-care behaviors, and 
exposure to other environmental factors such as pollutants.
Kim et al found COPD patients with and without 
periodontitis were significantly older, less well educated, took 
less exercise, had lower income, smoked more, and had a 
greater alcohol intake.108 Chung et al also noted that the COPD 
patients were generally less well educated, had a lower income, 
smoked more, and drank more alcohol.96 The COPD patients in 
Prasanna’s study were also noted to belong to a lower income 
group, were more illiterate, and were of a lower socioeconomic 
status regardless of periodontal status.40 Holtfreter et al found 
that patients with higher indices of periodontitis were less well 
educated and more often current smokers and had higher levels 
of systemic inflammation and worse lung function.101 All these 
studies indicate significant confounders that likely impact on 
results published to date even though Bhavsar et al did not find 
any differences in socioeconomic status or educational qualifi-
cations between their COPD cohort and control groups.95
Dental habits
It seems intuitive that poor dental hygiene would also 
increase the prevalence of periodontal diseases and may 
reflect education and socioeconomic status. Thus, it is 
important that future studies assessing specific comorbid 
associations between COPD and periodontitis also include 
the potential confounding effect of dental habits.
In support of this, Bhavsar et al found patients in the 
COPD group, as a whole, had significantly reduced brushing 
frequency compared with a non-COPD group (independent of 
periodontal status).95 Similarly, Liu et al found that a higher 
proportion of patients with frequent COPD exacerbations 
brushed their teeth less than once per day and had higher PI 
scores after adjusting for other confounding factors.104 Wang 
et al also found that their COPD group generally had lower 
tooth brushing times (P,0.0001) and oral health knowledge 
scores (P,0.0001) and were also less likely to use dental 
floss and have regular dental visits than controls.97 All these 
studies indicate that lifestyle factors are also likely to be 
a crucial confounder when seeking associations and/or a 
common pathophysiological process.
Conclusion
The available evidence still provides some support for the 
hypothesis that COPD and periodontitis could be causally 
linked; raising the possibility that treatment of one could influ-
ence the severity and progression of the other. There are simi-
larities in disease mechanisms (that of dysfunctional neutrophil 
behaviors, sustained neutrophilic inflammation, and connec-
tive tissue loss) that suggest a shared pathophysiology and 
support epidemiological evidence of association. However, 
some studies conducted to date have significant limitations 
that need to be overcome in order to provide a clear picture. 
First, the presence and severity of periodontitis must be defined 
using robust criteria, and second, the diagnosis of COPD must 
be confirmed according to international standards; this will 
require close collaboration between dentists and physicians. 
Third, known relevant confounding factors must be recorded 
and taken into account, and this will require a significant 
sample size to allow appropriate statistical modeling. Finally, 
the inflammatory profiles (systemically or locally) in groups 
of patients with COPD and periodontitis need to be compared 
with that of matched patients with COPD and no periodon-
titis. Such studies could then be used to design appropriately 
powered interventional trials to determine whether treating 
periodontitis is of benefit to COPD-related lung disease.
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